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a b s t r a c t
Transmission of chikungunya virus (CHIKV) to humans is initiated by puncture of the skin by a blood-
feeding Aedes mosquito. Despite the growing knowledge accumulated on CHIKV, the interplay between
skin cells and CHIKV following inoculation still remains unclear. In this study we questioned the
behavior of human keratinocytes, the predominant cell population in the skin, following viral challenge.
We report that CHIKV rapidly elicits an innate immune response in these cells leading to the enhanced
transcription of type I/II and type III interferon genes. Concomitantly, we show that despite viral particles
internalization into Rab5-positive endosomes and efﬁcient fusion of virus and cell membranes,
keratinocytes poorly replicate CHIKV as attested by absence of nonstructural proteins and genomic
RNA synthesis. Accordingly, human keratinocytes behave as an antiviral defense against CHIKV infection
rather than as a primary targets for initial replication. This picture signiﬁcantly differs from that reported
for Dengue and West Nile mosquito-borne viruses.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The skin is at the interface of vector-to-human transmission of
mosquito-borne viruses. The transmission cycle of these patho-
gens is initiated when virus-containing ﬂuids are ingested by a
blood feeding vector by skin puncture of an infected vertebrate.
Once the virus has replicated in the insect vector, it reaches the
salivary glands where replication leads to the presence of high
infectious titers (Luplertlop et al., 2011; Salazar et al., 2007;
Vazeille et al., 2010; Ziegler et al., 2011). During a subsequent
blood meal, skin probing by the proboscis of the infected mosquito
results in the extravascular delivery of the virus in both the
epidermis and dermis.
The human skin is a complex organ composed of multiple cell
types. Besides its role of physical barrier against environmental
aggressions, the presence of resident and migratory immunocompe-
tent cells gives the human skin a key role in the detection and defense
against pathogens. The capacity of mosquito-borne viruses to replicate
in cells at the anatomical site of mosquito bite which implies counter-
acting innate immune responses in these cells, together with the
encounter of competent cells with migratory properties will deter-
mine the establishment of a systemic infection and the continuation of
transmission cycles between the vertebrate host and the arthropod
vector (for revue see (Briant et al., 2014)). Keratinocytes that represent
the major cell population in the epidermis perfectly illustrate the dual
role of the skin upon virus inoculation. Indeed, these cells present in
the outermost corniﬁed skin layer as well as in the deeper epidermis
not only contribute to the substructure of the skin but also fulﬁll a key
role in the detection and control of pathogens facilitated by the
expression of pattern recognition receptors (Nestle et al., 2009). In
the recent years, we, and others, demonstrated that keratinocytes are
primary targets for initial replication of arboviruses sharing the
common property to be inoculated in the vertebrate skin by blood-
feeding mosquitoes. Indeed, keratinocytes efﬁciently replicate Dengue
virus (DENV) and West Nile virus (WNV) and this cell type was
therefore proposed as a major player for host colonization
by ﬂaviviruses (Lim et al., 2011; Limon-Flores et al., 2005;
Surasombatpattana et al., 2011). Both viruses also stimulate the
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transcriptional activation of intracellular RNA virus sensors, IFN genes
and antimicrobial proteins attesting for the establishment of antiviral
innate immunity in this cell type (Surasombatpattana et al., 2011).
Similarly to DENV and WNV, the chikungunya alphavirus (CHIKV)
(family Togaviridae) is transmitted to humans through skin puncture
by infected mosquitoes. In humans, CHIKV replication is responsible
for an acute syndrome lasting for 3–7 days characterized by a febrile
illness, headache, joint pain, myalgia and by a cutaneous rash in
30–40% of infected patients (Schwartz and Albert, 2010). Hallmarks
of acute CHIKV infection also rely on the elicitation of a strong
immune response involving the production of proinﬂammatory
mediators including TNF-α/β, IFN-α,-β and -γ, IL-4 and IL-10 and
MCP-1 in tissues (Rulli et al., 2007; Thangamani et al., 2010;
Wauquier et al., 2011). In CHIKV-challenged mice a burst of IFNs
production occurs locally at the site of inoculation (Schilte et al.,
2010). Histological analysis of tissues collected from these animal or
from experimentally inoculated macaques revealed that the presence
of CHIKV antigens and RNA in the skin is preferential in ﬁbroblasts
(Couderc et al., 2008; Labadie et al., 2010; Rudd et al., 2012; Schilte
et al., 2010) while its presence in keratinocytes has never been
reported so far. The present study was therefore, designed to
determine the behavior of human keratinocytes upon CHIKV chal-
lenge. Here, we show that infection of keratinocytes elicits a strong
antiviral program attested by the signiﬁcant transcriptional activation
of pattern-recognition receptors genes together with increased type
I, II and III interferons mRNA levels. Consistent with these data we
report that human primary and immortalized keratinocytes can be
infected by CHIKV as attested by viral particles endocytosis and
fusion of the viral envelope glycoproteins with cellular membranes.
However, viral RNA synthesis was impaired in these cells and de novo
viral particle release could not be detected attesting for an intracel-
lular block of CHIKV replication in human keratinocytes. Altogether,
our data evidence that keratinocytes behave as key defense against
CHIKV in the skin and provide new insight into the picture of early
events of CHIKV infection, a pathogen that continues spreading
across the Caribbean islands (Van Bortel et al., 2014) and represents
a major public health risk in many parts of the world, including in
temperate areas colonized with the appropriate strains of competent
mosquitoes (Angelini et al., 2008; Vazeille et al., 2008).
Results
Primary and immortalized human keratinocytes are poorly
permissive for CHIKV replication
First, we investigated the capacity of human keratinocytes to
support CHIKV replication. To this end, primary human epidermal
keratinocytes obtained from human foreskins (referred below as
NHEK) or the HaCaT cell line, a spontaneously immortalized
human keratinocytes cell line representing a relevant model to
study keratinocytes in vitro (Boukamp et al., 1988), were chal-
lenged with CHIKV-LR-3’GFP viruses encoding a GFP reporter gene
at the 50 end of structural proteins (Tsetsarkin et al., 2006).
Cultures of HEK293T human kidney epithelial cells, referred below
as 293T, well known as CHIKV-permissive cells (Bernard et al.,
2010) were processed in similar conditions and used as a positive
control. Viral replication was monitored over time by detection of
GFP expression in the culture. As GFP is not incorporated into
virions produced with the CHIKV-LR-3’GFP subgenomic clone,
green ﬂuorescence in the culture provides direct evidence of viral
replication (Vanlandingham et al., 2005). After 24 h in culture,
approximately 60% of 293T cells exposed to a MOI of 1 were GFP-
positive (Fig. 1A). GFP expression reached 80% after 48 h. In
contrast, below 2% GFP-positive cells were detected in cultures
of NHEK and HaCaT cells at any time. These rare GFP-positive cells
rapidly underwent apoptosis as attested by caspase-8/-9 detection
(Supplementary Figure 1). No sign of viral spreading in the culture
was detected even when these cells were exposed to higher
multiplicity of infection (MOI¼50) or when cultured for eight
days (data not shown). Similar results were ﬁnally obtained using
immortalized SCC12B2 and SCC12F2 squamous carcinoma kerati-
nocytes with distinct differentiation stages as well as using adult
primary human keratinocytes (data not shown). The absence of
CHIKV replication in primary and immortalized keratinocytes was
not the result of a general refractory state since keratinocytes
maintained in our culture conditions were successfully infected
with Dengue virus or West Nile virus (Supplementary Figure 2)
in agreement with previous observations (Lim et al., 2011;
Surasombatpattana et al., 2011).
Alphaviruses, and especially CHIKV, produce a marked cyto-
pathic effect in vertebrate cell cultures (Sourisseau et al., 2007).
Here, we found that CHIKV used at a MOI of 1, decreased the
viability of 293T by more than 20% and 60% cells at 48 and 72 h
post-infection respectively (Fig. 1B). In identical culture conditions,
poor cytopathic effect was observed in HaCaT and NHEK cells
along the experiment, with more than 90% of the cells remaining
unaffected by CHIKV after 72 h of cultivation. Next, we investi-
gated progeny virions production in these cultures. NHEK or
HaCaT cells were challenged with CHIKV for 2 h at 37 1C. After
extensive washings and trypsin treatment to remove viral particles
docked to the membranes, the cells were maintained in culture for
an additional 24 h or 48 h. Then, de novo production of viral
particles was monitored by qRT-PCR ampliﬁcation of CHIKV RNA
in culture supernatants. As shown in Fig. 1C, viral genomic RNA
was detected at background levels in these samples while RNA
copy numbers increased overtime to reach values above 107
copies/ml in supernatants of 293T cells processed in identical
conditions. When incubated with fresh cultures of permissive
293T cells, supernatants of CHIKV-challenged NHEK or HaCaT
from Fig. 1C were unable to produce GFP (data not shown),
attesting for the absence of release of infectious particles. Alto-
gether, these data show that human keratinocytes are unable to
support productive infection after CHIKV challenge.
CHIKV particles are endocyted by HaCaT cells
In permissive cells, CHIKV infection is initiated by E2 envelope
glycoproteins binding to an uncharacterized receptor and endocytosis
of the viral particle into Rab5-positive endosomes where fusion occurs
(Bernard et al., 2010). The capacity of CHIKV particles to be endocyted
in keratinocytes was therefore examined by immunoﬂuorescence
detection of viral structural proteins. HaCaT cells were incubated with
CHIKV (MOI¼100) for 1 h at 37 1C. After extensive washings, the cells
were permeabilized and stained with anti-capsid mAbs and with
Alexa 647-labeled wheat germ agglutinin (WGA), a carbohydrate-
binding lectin that recognizes sialic acid and N-acetylgucosaminyl
sugar residues predominantly found in cellular membranes. Confocal
ﬂuorescence microscopy analysis (Fig. 2A) revealed the presence of
capsid proteins at the cell periphery. Optical sections performed from
a series of stack sections across Z axis and spectral analysis conﬁrmed
the presence of green ﬂuorescent spots corresponding to capsid
antigens in the cytoplasm, beneath the plasma membrane. No signal
was evident in non-infected cells, conﬁrming the speciﬁcity of the
assay (Fig. 2A, left panel). The presence of intracytoplasmic capsids
was further conﬁrmed by electron microscopy analysis. HaCaT cells
were challenged for 10 min with CHIKV used at a high infectious dose
(MOI¼500) in order to increase the probability to detect CHIKV
particles in thin sections. Micrographs presented in Fig. 2B conﬁrmed
the presence of bona ﬁde viral particles in the cytoplasm of immorta-
lized keratinocytes. Next, the capacity of CHIKV capsids to colocalize
with Rab5-positive endosomes was examined in HaCaT cells. Confocal
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analysis of cells co-labeled with antibodies speciﬁc of capsid protein
(green) and of Rab5 antigens (red) revealed the presence of a yellow/
orange granular labeling in the cytoplasm of cells challenged with
CHIKV for 30 min (Fig. 2C). The colocalization of green and red
ﬂuorescences in some areas was conﬁrmed by spectral analysis.
Quantitative analysis of colocalization events revealed that about
15%, of cell-associated CHIKV antigens detected in human keratino-
cytes colocalized with the early endosomal compartment. Similarly, 10
to 15% of intracytoplasmic capsids detected in CHIKV-infected 293T
cells merged with Rab5 signal when processed in these experimental
conditions (data not shown). According to these results, CHIKV
particles were apparently endocyted and routed to early endosomes
with similar efﬁciency in permissive 293T cells and HaCaT cells.
Keratinocytes membranes support fusion with CHIKV envelope
glycoproteins
Next, we questioned the capacity of CHIKV envelope to fuse with
cellular membranes in human keratinocytes using retroviral parti-
cles pseudotyped with CHIKV envelope glycoproteins. 293STAR cells
(Ikeda et al., 2003) containing a stable retroviral vector expressing
human immunodeﬁciency type 1 (HIV-1) Gag and Pol proteins
allowing extracellular release of retroviral pseudoparticles (VLPs)
were transfected with the pCAGGS-Env plasmid encoding a human
codon optimized CHIKV E3/E2/E1 gene (Salvador et al., 2009). The
pHR-CMV-GFP reporter plasmid containing a GFP reporter gene
inserted downstream the hCMV immediate early reporter, the HIV-1
packaging signal required for incorporation into VLPs and retroviral
LTR sequences necessary for integration in the host cell genome was
added to the transfection mixture (Fig. 3A). Control pseudotypes
were produced by replacing the CHIKV envelope plasmid by a vector
encoding the vesicular stomatitis virus G glycoprotein (VSV-G).
Pseudoparticles released in supernatants of transfected cells were
of approximately 100–120 nm in size when processed for electron
microscopy imaging and contained a conical capsid characteristic of
mature HIV-1 structural proteins (Fig. 3B) (Brun et al., 2008).
Western blot analysis conﬁrmed that CHIKV envelope was efﬁciently
expressed in producing cells and incorporated into VLPs (Fig. 3C).
Moreover, retroviral proteins present at the immature state in cell
lysates (Pr55Gag) were efﬁciently cleaved into mature p24CA capsid
proteins in cell free samples attesting for the maturation of viral
particles. Then, CHIKV- or VSV-G-pseudotyped VLPs normalized
according to HIV-1 structural proteins content (50 ng p24CA) were
incubated with 293T cells in order to determine the functionality of
these reagents. As shown in Fig. 3D, both CHIKV- and VSV-G-
pseudotyped VLPs directed expression of GFP in the culture, attest-
ing for the capacity of viral glycoproteins to fuse with cells
membranes and to deliver a GFP reporter plasmid to the host cell.
GFP reporter gene expression was also detected at similar levels in
HaCaT cells incubated with normalized amounts of CHIKV envelope-
pseudotyped VLPs (Fig. 3D). In these experiments the absence
of ﬂuorescence in HaCaT cells incubated with VLPs lacking
envelope attested for the absence of pseudo-transduction event
(data not shown). Accordingly, membranes of immortalized HaCaT
keratinocytes supported efﬁcient fusion with CHIKV envelope
glycoproteins.
Analysis of early CHIKV replication events in human keratinocytes
Expression of non-structural proteins nsPs represents an early
event in CHIKV life cycle. Once assembled to form the replication
complex, these proteins allow replication and intracellular accu-
mulation of the viral genome (Solignat et al., 2009). Thus, early
CHIKV replication steps in HaCaT cells were further examined
using a CHIKV strain encoding a mCherry ﬂuorescent reporter in
frame with the nsP3 nonstructural protein (Kummerer et al.,
2012). When used at a MOI of 10 to infect 293T cells, this reporter
virus generates a red punctate ﬂuorescence detectable within 9 h
of infection (Fig. 4A). The ﬂuorescence persisted and accumulated
over time in the culture. Used in similar conditions to infect HaCaT
Fig. 1. Human keratinocytes are naturally poorly permissive to CHIKV replication. (A) HaCaT immortalized keratinocytes or neonate primary human keratinocytes
(NHEK) were exposed to CHIKV reporter viruses at the indicated MOI. Expression of the GFP reporter gene attesting for viral replication was monitored over time using
ﬂuorescence microscopy. Permissive 293T human epithelial cells exposed to a MOI of 1 and then processed in similar conditions are shown as positive control. Percentage of
ﬂuorescent cells counted in the culture at 48H post-CHIKV exposure is indicated. (B) CHIKV-exposed HaCaT, NHEK and 293T cells from Fig. 1A were analyzed for cytopathic
effects along time using Trypan Blue exclusion assay. Percentages of viable cells in the culture are indicated. (C) Production of progeny virions in culture supernatants from
Fig. 1A was monitored by qRT-PCR ampliﬁcation of CHIKV genomic RNA. CHIKV RNA copy numbers were normalized to GAPDH mRNA copies in the producing cells. Values
are the mean of three separate experiments performed in duplicate7SD.
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cells this reporter virus generated very poor ﬂuorescence even
when analyzed 48 h post-challenge. When RNA genome synthesis
was monitored in the corresponding cultures, qRT-PCR analysis
showed a rapid accumulation of CHIKV genomic RNA in 293T cells
starting as soon as 6 h post-infection and attesting for the active
viral replication (Fig. 4B). To the opposite, RNA copy numbers in
HaCaT cells remained stable over time and were below the RNA
levels contained in the inoculum (input) attesting for the absence
of CHIKV RNA synthesis in these cells.
CHIKV activates an innate immune response in human keratinocytes
Keratinocytes respond to mosquito-borne viruses challenge by
mounting an antiviral program characterized by the ﬁnal upregu-
lation of IFNs genes (Surasombatpattana et al., 2011). This cellular
response relies on the transcriptional activation of cytoplasmic
RNA helicases retinoic acid-inducible gene I (RIG-I), melanoma
differentiation-associated gene 5 (MDA5), myeloid primary differ-
enciation response 88 (MyD88) as well as toll-like receptor-3
(TLR3) and on upregulation of IFN regulatory factors IRF3 and
IRF7 mRNAs. We have therefore examined the transcriptional
induction of innate antiviral genes upon CHIKV challenge of this
particular cell type. Total RNA prepared from primary human
keratinocytes challenged with CHIKV (MOI of 10) for 6 or 24 h
was subjected to qRT-PCR analysis using primers for the above
mentioned genes. mRNA copy numbers were normalized accord-
ing to 18S mRNA copies and values were compared with that
obtained from cells incubated with supernatant from mock-
infected C6/36 cells used to produce CHIKV stocks. As shown in
Fig. 5, relative expression of RIG-I (1.670.6 folds), MDA-5
(3.970.8 folds) and MyD88 (3.270.7 folds) were signiﬁcantly
upregulated after 6 h of CHIKV-challenge when compared to
mock-challenged cells. The relative expression of TLR3 was not
signiﬁcantly affected. In addition, CHIKV challenge generated a
370.8 and a 3.971 folds induction of IRF3 and IRF7 mRNAs
respectively. Finally, mRNAs of IFN-β and IFNγ were increased by
3.871.9 and 6.271.5 folds respectively upon CHIKV challenge.
Interestingly, transcriptional activation of these genes was not
observed after 24 h of infection. Finally, since keratinocytes are
cells that both produce and respond to type III interferons (IFN-III)
(Odendall et al., 2014), we analyzed the corresponding mRNA
levels in response to CHIKV. As shown in Fig. 6A, virus exposure
resulted in a signiﬁcant and continuing increase in IFN-λ mRNA
levels starting from 6 h post-exposure and reaching a 800-fold
induction after 48 h. Altogether these data indicate that CHIKV
induced a signiﬁcant but transient induction of type I and type II
IFN genes in human keratinocytes and results in a sustained type
III IFN genes expression in these cells.
CHIKV replication in keratinocytes with perturbation of the IFN
signalling pathway
IFNs expression signiﬁcantly reduces CHIKV replication in IFNs-
responsive cell types (Schilte et al., 2010; Sourisseau et al., 2007).
We therefore investigated the consequences of IFNs signaling
perturbations on CHIKV replication in keratinocytes. First, HaCaT
cells were transfected with siRNA targeting either IRF3 or IRF7
transcription factors or with non-targeting siRNA duplexes. After
Fig. 2. Viral antigens and assembled particles are detected in the cytoplasm of CHIKV-challenged HaCaT cells. (A) Confocal microscopy analysis of HaCaT cells challenged
for 1 h with CHIKV (MOI of 100). Anti-capsid antibodies were revealed with Alexa 488-conjugated secondary antibodies (green), nucleus and cell membranes were labeled
with Hoescht dye (blue) and Alexa 647-conjugated WGA (red) respectively. The lateral panels correspond to orthogonal projections of Z-stacks of 12 sequential optical
sections spaced 300 nm each, acquired with 100 ms exposure. The white box in the merged image indicates the position of orthogonal analysis. The left panel shows the
absence of background signal in uninfected cells (UI). (B) HaCaT cells challenged with CHIKV (MOI¼500) for 10 min were processed for electron microscopy. An arrow
indicates the presence of intracytoplasmic CHIKV particle. Enlargements of the cytoplasm containing assembled viral particles are shown. (C) CHIKV capsids (green) and
Rab5 endosomal protein (red) were immunostained with speciﬁc antibodies. Nuclei were labeled with Hoechst reagent (blue). Orthogonal view showing the colocalization of
capsids with Rab5 in high magniﬁcation and orthogonal analysis performed at the position indicated by the white line.
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72 h in culture, decreased IRF3 and IRF7 expression was evidenced
by western blotting analysis of cells lysates (Fig. 7A). Then, the
cells were infected with CHIKV reporter viruses. As shown in
Fig. 7B, no difference in virus replication was observed between
cells transfected with IRF3 or IRF7 targeting siRNAs and the non-
targeting control. According to this result, the deregulation of IRF3
or IRF7 genes expression was unable to restore CHIKV replication
in HaCaT cells. IRF3 and IRF7 phosphorylation by the TANK-
binding kinase (TBK1) and IKKε and subsequent nuclear translo-
cation of these transcription factors are central regulatory steps of
the type I interferon-meditated antiviral responses (Sharma et al.,
2003). To further evaluate the consequences of IRF3- and IRF7-
dependent signaling on the control of CHIKV replication in
keratinocytes we took advantage of BX795, a potent inhibitor of
TBK1- and IKKε-mediated IRF3 activation (Bain et al., 2007; Clark
et al., 2009). HaCaT cells were preincubated with BX795 used at
various concentrations before CHIKV challenge. In these condi-
tions, no sign of viral replication could be evidenced from the
cultures (Fig. 7C). Finally, the capacity of anti-IFNα/β neutralizing
antibodies to control a possible autocrine secretion of type I IFN in
the culture was also inefﬁcient at enhancing CHIKV replication
(Fig. 7D). In an attempt to counteract any antiviral effects of IFN-λ
in the culture we next pre-treated HaCaT cells with AG490, a
potent Jak2 inhibitor recently reported to block IFN-λ antiviral
effects (Odendall et al., 2014). In our hands, CHIKV replication
could not be restored by this inhibitor (Fig. 6B). Accordingly,
neither of the strategies used in this study increased CHIKV-
replication in human keratinocytes.
Discussion
The present study was conceived to evaluate the behavior of
human keratinocytes when challenged with CHIKV. Keratinocytes
represent the primary cell population (more than 95%) in the skin
(Bos, 2010). This feature has prompted studies aimed at determin-
ing the role of this particular cell type as portal of entry for
infection of vertebrates by arthropod-borne viruses. In this
context, West Nile virus that replicates in the skin of mice infected
by blood-suckling mosquitoes was shown to productively infect
keratinocytes (Lim et al., 2011). In the recent years, we also
reported that Dengue virus, another mosquito-borne pathogen,
capable to infect human skin explants (Limon-Flores et al., 2005),
is actively replicated in cultures of human keratinocytes
(Surasombatpattana et al., 2011). According to these results kera-
tinocytes were proposed as key players of early arboviral infection
capable to produce high levels of infectious viruses in the skin
favoring viral dissemination to the entire body. Here, we report
that CHIKV poorly replicates in cultures of primary and immorta-
lized keratinocytes and despite differentiation status of these cells
may be crucial for infection/replication of some viruses (e.g.
human papillomavirus (Beglin et al., 2009)), CHIKV behaved
independently from the maturation stage of keratinocytes used
in this study.
It is well known that alphaviruses display a wide spectrum of
target cells. Regarding CHIKV, a large variety of in vitro susceptible
cells has been identiﬁed, including ﬁbroblasts, hepatocytes, neurons,
astrocytes, microglial cells, neuroblastoma cells, skeletal muscle
progenitor cells, epithelial and endothelial cells (Salvador et al.,
2009; Sourisseau et al., 2007; Wikan et al., 2012). In line with this
observation, immunohistology analysis detected viral RNA and anti-
gens inside a variety of organs in infected humans and experimen-
tally infected animals, including lymph nodes, spleen, liver, muscle
and joints during the acute phase of the infection (Couderc et al.,
2008; Her et al., 2010; Labadie et al., 2010; Ozden et al., 2007).
Nevertheless, a series of cells can resist CHIKV infection or replica-
tion. Immune cells including lymphocytes, dendritic and natural
killer cells and well as brain endothelial cells are unable to bind
CHIKV envelope glycoproteins and are refractory to infection prob-
ably due to the lack of surface receptor(s) and/or attachment factor
(Salvador et al., 2009; Sourisseau et al., 2007). Although permissive
for CHIKV envelope binding and viral fusion, alveolar epithelial cells,
muscle ﬁbers, brain-derived microglial cells and human syncytiotro-
phoblast cells are unable to replicate the virus and to release progeny
virions (Solignat et al., 2009; Sourisseau et al., 2007). The data
reported herein extend these observations to keratinocytes. Despite
Fig. 3. CHIKV envelope-pseudotyped particles efﬁciently fuse with HaCaT cells membranes. (A) Organization of plasmids used for production of CHIKV- or VSV-G-
pseudotyped retroviral particles. (B) Electron microscopy visualization of CHIKV-pseudotyped particles. (C) Immunoblot detection of envelope glycoproteins (Env) (upper
panel) and Pr55Gag and p24CA retroviral structural proteins in VLPs-producing cells and in the corresponding cell free samples. (D) Expression of the pHR-CMV-GFP reported
plasmid in 293T or HaCaT cells cultured with VSV-G- or CHIKV-pseudotyped VLPs.
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internalizing viral particles that colocalized with Rab5-positive
endosomal compartments competent for CHIKV entry in permissive
cells (Bernard et al., 2010) and while supporting fusion with viral
membranes, keratinocytes are unable to replicate the virus. In these
cells, expression of non-structural proteins and synthesis of genomic
RNA are impaired. These results produced using ex vivo model of
infection corroborate histological analysis performed in experimen-
tally infected animals. Indeed, intradermal injection of CHIKV in
mouse ears mimicking a mosquito bite evidenced no disseminated
viral production at the skin level (Couderc et al., 2008). Viral antigens
were instead detected at the level of sebaceous glands, vessels and
cartilage and replicationwas detected in ﬁbroblasts, in the basal layer
of the skin (Couderc et al., 2008; Rudd et al., 2012; Schilte et al.,
2010). Our observations are therefore in line with the predominant
role of ﬁbroblasts proposed during the earliest events in mosquito-
to-human transmission of CHIKV.
According to the capacity of IFNs to control CHIKV in mammals
(Couderc et al., 2008; Olagnier et al., 2014; Schilte et al., 2010) and
in cell cultures (Sourisseau et al., 2007), the stimulation of this
signaling axis was considered in our study. Analyzing the intracel-
lular innate immune responses elicited following infection, we
found that CHIKV signiﬁcantly upregulated transcription of a
number of cytosolic sensors namely RIG-I, MDA5 and MyD88. These
pattern recognition receptors are responsible for sensing the pre-
sence of microbial invasion through recognition of RNA species
containing 50 triphosphates and dsRNA fragments (for review see
(Jensen and Thomsen, 2012). CHIKV infection also activated expres-
sion of IRF3 and IRF7 transcription factors and subsequently
stimulated IRF-dependent antiviral genes, including IFN-β and
IFN-γ. These data are in line with the early innate immune response
against CHIKV elicited in ex vivo cultures and at the site of CHIKV
inoculation in experimentally infected mice (Schilte et al., 2010;
Thangamani et al., 2010; Thon-Hon et al., 2012). Interestingly, we
observed that IFN-λ mRNA is highly upregulated in CHIKV-
challenged keratinocytes. IFN-λ is part of IFN-III, the most recently
described group of small helical cytokines capable of inducing an
antiviral state in responsive cells mainly reported as epithelial
surfaces and especially keratinocytes (Witte et al., 2009). Its
capacity to control replication of viral pathogens, including rota-
virus, inﬂuenza and metapneumovirus human has been reported
(Hermant and Michiels, 2014). Conversely to the regulation of IFN-I
and –II genes expression that is relatively well characterized the
regulation of IFN-III is less known. However, as IRF-3 and IRF-7
were proposed as common regulators of type I, II and III IFNs
induction (Osterlund et al., 2007) strategies targeting these tran-
scription factors were considered in this study. The use of RNA
interference strategies and chemical inhibitors validated as pertur-
bators of IRF3- and IRF7-dependent IFN genes expression as well as
neutralizing anti-IFNα/βmAbs remained unsuccessful to relieve the
intracellular block of CHIKV replication in keratinocytes. However,
we cannot rule out that residual IRF3 or IRF7 was sufﬁcient to
support antiviral signaling inhibiting CHIKV replication. Moreover,
elucidation of events controlling IFN-λ genes activation will provide
new tools to decipher the respective contribution of IFN-λ tran-
scriptional activation and of intrinsic replication block in the control
of CHIKV replication in keratinocytes. Meanwhile, our study under-
lines the capacity of keratinocytes to behave as immune sentinels
against CHIKV rather than as initial targets for incoming virions and
supports that because of its absence of replication in keratinocytes,
CHIKV likely behaves differently of DENV andWNVmosquito-borne
during early events of vertebrate host colonization.
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Material and methods
Cells
Aedes albopictus C6/36 cells (ATCC number CCRL-1660) were
grown at 28 1C in RPMI medium (Gibco Life Technologies) supple-
mented with 10% fetal calf serum (Lonza) as previously described
(Bernard et al., 2010). Primary human epidermal keratinocytes were
obtained from neonatal foreskins (Lonza) and cultured in Keratino-
cyte Basal Medium-2 supplemented with KGM-2 supplement and
growth factors (Lonza). The HaCaT cell line (CLS lines service number
Fig. 4. Expression of CHIKV nonstructural proteins and de novo genomic RNA
synthesis are impaired in HaCaT cells. (A) 293T cells or HaCaT cells were
challenged with a CHIKV reporter strain expressing the mCherry ﬂuorescent
protein in frame with the nsP3 protein. Fluorescence in the cultures was monitored
over time using ﬂuorescence microscopy. (B) Viral genomic RNA in the cells was
quantiﬁed over time using qRT-PCR ampliﬁcation. Copy numbers were normalized
relative to GAPDH mRNA copies in the samples. Control experiments consisted of
uninfected cells (UI) and of CHIKV-challenged cells subjected to trypsin-digestion
(Trypsin) to remove contaminating RNA contained in membrane-bound particles.
RNA copies number contained in the viral input is also indicated (Input). Values
represent mean of duplicate experiments7SD.
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300493) and the HEK293T cell line (ATCC number ACS-4500) were
cultured in DMEM medium (Gibco Life Technologies) supplemented
with antibiotics and 10% FCS. All human cells were grown at 37 1C in
a 5% CO2 atmosphere.
Viruses
CHIKV stocks were produced as follows. The pCHIKV-LR-30GFP
(LR-OPY1-GFP strain) full length CHIKV subgenomic clone expressing
GFP at the 50 end of structural genes (Tsetsarkin et al., 2006) and the
CHIKV clone containing the mCherry sequence in frame with nsP3
gene (Kummerer et al., 2012) were transcribed in vitro from the SP6
promoter and the T7 promoter respectively using the mMESSAGE
mMACHINE kit (Ambion). RNA (0.5 μg) was then electroporated into
5106 BHK-21 cells with two pulses at 1.5 kV, 25 mF and 1V.
Culture supernatant was harvested at 24 h post transfection and used
to infect C6/36 Aedes albopictus cells. After two days, supernatant was
collected, ﬁltered through 0.45 mm membrane, aliquoted and stored
at 80 1C. Viral stocks were tittered using plaque assays as previously
reported (Bernard et al., 2010).
Antibodies and reagents
C42 mAbs raised to Semliki Forest nucleocapsid react with the
CHIKV capsid protein (Greiser-Wilke et al., 1989). Anti-Rab5 mAbs
were from Santa-Cruz. Alexa-Fluor 488-conjugated anti-mouse Ig
secondary antibodies and Alexa-Fluor 594-conjugated anti-rabbit
Ig were from Life Technologies. Alexa 647-labeled wheat germ
agglutinin was purchased from Molecular Probes. Anti-human
IFNα/β neutralizing serum (Mogensen et al., 1975) kindly provided
by G. Uzé (UMR5235 CNRS) was diluted 1:100 in culture medium
1 h before viral challenge. BX795 and AG490 inhibitors, purchased
from Invivogen, were dissolved in DMSO and used as indicated in
the text.
Production of CHIKV pseudotypes
Production of CHIKV pseudotypes was achieved through transfec-
tion of the 293TSTAR cell line, constitutively expressing HIV-1
gag and pol genes (Ikeda et al., 2003). Cells were co-transfected
with the pCAGGS-EnvCHIKV plasmid encoding codon-optimized
Fig. 5. CHIKV stimulates IFN signaling pathways in primary human keratinocytes. Relative expression of RIG-I, MDA-5, MyD88, TLR-3, IRF3, IRF7, IFN-β and IFN-γ was
monitored by real-time quantitative RT-PCR in primary human keratinocytes challenged with CHIKV (MOI of 10) for 6 h and 24 h (black bars) or in cells cultured for the same
duration in the presence of poly(I:C) (white bars). RNA copies numbers were normalized according to 18S mRNA levels detected in the same sample. Results are expressed as
fold induction relative to mock-infected cells. All experiments were done in triplicates and results are expressed as mean7standard error. Statistical signiﬁcance (po0.05) is
indicated by n.
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CHIKV envelope glycoproteins (Salvador et al., 2009) and with the
pHR-CMV-GFP reporter plasmid, (D. Rekosh, University of Virginia),
derived from the pHR vector (Naldini et al., 1996) by insertion of a
GFP gene in place of luciferase gene. Particles pseudotyped with the
vesicular stomatitis virus (VSV) glycoprotein G were produced by co-
transfection of the pHR-CMV-GFP with the pHEF-VSV-G plasmid
obtained through the AIDS Research and Reference Reagent Program,
NIAID, NIH (Chang et al., 1999). The JetPei transfection reagent
(PolyPlus Transfection) was used according to manufacturer’s recom-
mendations. Forty eight hours post-transfection, viral supernatants
were collected, ﬁltered on a 0.45 mmmembrane and ultracentrifuged
on a 20% sucrose cushion. Viral particles were resuspended in PBS
and tittered using the anti-HIV p24 Innotest ELISA assay (Innoge-
netics). Ectopic expression of proteins in the culture and incorpora-
tion into pseudoparticles was analyzed by immunoblot as previously
reported (Bernard et al., 2010).
Infection with CHIKV-reporter viruses
Primary or immortalized human keratinocytes were seeded in
plates to a conﬂuence of 70-80%. Then, cells were rinsed once with
PBS and the CHIKV virus diluted to the desired MOI was added to
the cells. The culture was incubated at 37 1C for the duration of the
experiment. Viral replication was monitored by visualization of
GFP or mCherry expression using ﬂuorescence microscopy (Eclipse
TS100, Nikon). For quantitative analysis of ﬂuorescence the cells
were lysed with RIPA buffer and ﬂuorescence was measured
directly from the cell lysate using an Inﬁnite F200PRO ﬂuorometer
(Tecan). Values were normalized according to protein content in
the sample determined using the BCA Assay (Pierce).
Quantitative RT-PCR detection of CHIKV RNA
Viral and cellular RNA were extracted with a TRizol-based protocol
and tested for mRNA purity and concentration using light absor-
bance. RNA (0.1 μg) was converted to cDNA with an oligodT (12:18)
primer (Invitrogen) and with Superscript III Reverse Transcriptase
(Life Technologies) according to manufacturer’s instructions. PCR
ampliﬁcation was carried out on 1/10th of cDNA in a reaction mix
containing 0.4 μM of each primer, and 5 μl SYBR Green master
ampliﬁcation mix (Fast start DNA Master plus SYBR Green I ampliﬁca-
tion kit, Roche Diagnostics). For each ampliﬁcation a control reaction
was performed in which DNA sample was replaced by water.
Reactions were subjected to a ﬁrst cycle of 10 min at 95 1C followed
by 40 ampliﬁcation cycles of 15 s at 95 1C and 60 s at 60 1C on the
RotorGene system (Labgene Scientiﬁc). Fluorescence signal was
recorded at the end of each cycle. A standard curve was generated
from 101 to 106 copies of pCHIKic-LR-50GFP plasmid. Primers used for
ampliﬁcation were: 50–GGCAGTGGTCCCAGATAATTCAAG-30 and 50–
GCTGTCTAGATCCACCCCATACATG-30.
Immunoﬂuorescence labeling and confocal microscopy
Cells were grown on glass coverslips to 50–60% conﬂuence and
challenged with CHIKV for the indicated time. After extensive
washings in PBS, the cells were ﬁxed 20 min at room temperature
in 4% formaldehyde (Sigma Aldrich) and permeabilized for 10 min
at 20 1C with methanol. After blocking in PBS containing 2% fetal
calf serum and 0.1% Tween 20, the cells were incubated overnight
at 4 1C with the indicated primary antibodies and for 1 h with the
appropriated secondary reagents. Hoechst dye (Sigma-Aldrich)
was used to stain the nucleus. After ﬁnal washes, coverslips were
mounted with ProLong Gold anti-fade reagent (Invitrogen). Images
were acquired using a Leica SP5-SMD scanning confocal micro-
scope (Leica) equipped with a 63 , 1.4 numerical aperture Leica
Apochromat oil objective. Confocal Z-slices of 0.3 or 0.5 μm were
collected using the LAS AF software (Leica). Orthogonal views were
generated by the Image J software and colocalization was analyzed
with the Imaris software (Bitplane Scientiﬁc Software).
Electron microscopy imaging
Cells were processed for thin-layer electron microscopy as
described previously (Brun et al., 2008). Brieﬂy, samples were
ﬁxed for 1 h at 4 1C in a solution containing 2.5% glutaraldehyde in
0.1 M cacodylate buffer pH 7.4. Cells were then rinsed three times
in cacodylate buffer and post-ﬁxed with 1% OsO4. After an
additional washing, the cells were incubated for 30 min in 0.5%
tannic acid. Dehydratation was obtained with a graded series of
ethanol solutions (from 25 to 100%) before embedding in Epok
resin at 60 1C for 48 h. Ultra-thin sections were cut on a Reichert
OMU2 microtome and then examined under a Hitachi H7100
transmission electron Microscope at 75 kV.
Real-time PCR analysis of innate immune genes expression
Total RNA was extracted from primary keratinocytes using Tri
Reagent (Sigma-Aldrich) according to manufacturer’s protocol. The
RNA was resuspended in 30 μL of RNAse-free distilled water and
stored at 80 1C. For each condition, 0.5 μg total RNAwas subjected
to reverse transcription using M-MLV Reverse Transcription kit
(Promega). Real time PCR ampliﬁcation was run with Roche Light
Cycler LC480 device in a 8 μl reaction volume containing 2 μL cDNA,
400 nM of each primer, and 4 μl SYBR Green Master Mix (Roche).
The cycling conditions were 45 cycles of 95 1C for 15 s, 60 1C for 15 s
and 72 1C for 20 s. mRNA expression (fold induction) was quantiﬁed
by calculating 2ΔΔCT with 18 s mRNA as an endogenous control.
The speciﬁc primers used in this study have been previously
described (Surasombatpattana et al., 2011). Primers used for IFN-λ
are the following 50- CGCCTTGGAAGAGTCACTCA-30 and 50–GAAG
CCTCAGGTCCCAATTC-30.
siRNA transfection
HaCaT cells (12104) were seeded on 24-well plates. The
siRNA duplexes speciﬁc for IRF3 or IRF7 (Ambion) or non-
targeting negative control siRNA (Dharmacon) used at a ﬁnal
concentration of 10 nM was transfected using Lipofectamine
2000 (Life Technologies). After 72 h at 37 1C, the cells were washed
Fig. 6. Type III IFN-λ genes expression and CHIKV replication in keratinocytes.
(A) IFN-λ genes expression was monitored over time by real-time quantitative
RT-PCR in primary human keratinocytes challenged with CHIKV (MOI of 10). RNA
copies numbers were normalized according to 18S mRNA levels detected in the
same sample. Results are expressed as fold induction relative to mock-infected
cells. Statistical signiﬁcance (po0.05) is indicated by n. (B) Replication of the
LR-OPY1-GFP viruses in HaCaT cells preincubated with the AG490 Jak2 inhibitor
used at the indicated concentrations was evaluated by quantiﬁcation of the GFP
reporter expression. Untreated HaCaT and 293T cells are shown as controls.
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with PBS three times and infected with CHIKV at a MOI of 10.
Extinction of IRF3 or IRF7 expression at the time of virus infection
was determined by immunoblotting using speciﬁc antibodies
(Santa Cruz Biotechnologies).
Data analysis and statistical methods
All data are presented as means7SEM. A comparison of qPCR
values was made with the nonparametric Wilcox–Mann–Whitney
test. For all experiments, statistical signiﬁcance was accepted at
po0.05.
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